Pharmacokinetics and dosimetry of 188Re-pharmaceuticals
Authors:
- Guillermina Ferro-FloresGuillermina Ferro-Flores
- Consuelo Arteaga de MurphyCMConsuelo Arteaga de Murphy
- 1 September 2008
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 60 (12) , 1389-1401
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- The Bright Future of Radionuclides for Cancer TherapyAnti-Cancer Agents in Medicinal Chemistry, 2007
- Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”European Journal of Nuclear Medicine and Molecular Imaging, 2007
- Overview of dosimetry for systemic targeted radionuclide therapy (STaRT)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Monte Carlo microdosimetry of188Re- and131I-labelled anti-CD20Physics in Medicine & Biology, 2006
- Dosimetric characterization of radionuclides for systemic tumor therapy: Influence of particle range, photon emission, and subcellular distributionMedical Physics, 2006
- Targeting of Radio-Isotopes for Cancer TherapyCancer Biology & Therapy, 2004
- Radiolabeled antibody therapy in non-Hodgkins lymphoma: radiation protection, isotope comparisons and quality of life issuesCancer Treatment Reviews, 2004
- Radiation dosimetry in nuclear medicineApplied Radiation and Isotopes, 1999
- A Monte Carlo Program Converting Activity Distributions to Absorbed Dose Distributions in a Radionuclide Treatment Planning SystemActa Oncologica, 1996
- Processing of reactor-produced 188W for fabrication of clinical scale alumina-based 188W/188Re generatorsApplied Radiation and Isotopes, 1994